Conscience Symposium on Open Drug Discovery

Anke Mueller-Fahrnow Chair of Conscience's Board of Directors

Derek Lowe Author of In the Pipeline at Science.org and Director in Exploratory Chemical Biology at Novartis

Session Chair: Annabel Seyller Chief of Staff at the Montreal Neurological Institute-Hospital (The Neuro) and Chief Executive Officer of the Tanenbaum Open Science Institute (TOSI)

Linda Lafontaine Patient Advocate for Hereditary Spastic Paraplegia (HSP)

Jason Karamchandani Associate Professor in the Department of Pathology, a Neuropathologist at The Montreal Neurological Institute and Hospital, and Director of C-BIG

Gustavo Stolovitzky Founding Director, Biomedical Data Science Hub (Bio-DaSH) at NYU Langone Health, Professor, Department of Pathology at NYU Grossman School of Medicine, & Founding Chair, DREAM Challenges

Cas Wognum Senior Scientist at Valance Labs

Richard Gold Chief Policy and Partnerships Officer at Conscience, CIGI senior fellow, and James McGill Professor with McGill University's School of Law

Session Chair: Artem Cherkasov Professor in the Department of Urologic Sciences at the University of British Columbia, Senior Scientist at the Vancouver Prostate Centre, and Tier 1 Canada Research Chair in Precision Cancer Drug Design

Jenke Scheen Senior Scientist at ASAP Discovery & Open Molecular Software Foundation

Matthieu Schapira Professor in the Department of Pharmacology and Toxicology and PI, Research Informatics, Structural Genomics Consortium, University of Toronto

Peter Sampson VP of Drug Discovery and Development, Agora Open Science

Sonya MacParland Senior Scientist, University Health Network

Session Chair: Matthieu Schapira Professor in the Department of Pharmacology and Toxicology and PI, Research Informatics, Structural Genomics Consortium, University of Toronto

Albert A. Antolin Principle Investigator at the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO)

Karmen Čondić-Jurkić Executive Director at Open Molecular Software Foundation

Session Chair: Anne Fortier VP, Drug Discovery and Development at Conscience

Max Morgan CEO of the Agora Open Science Trust & General Counsel of the Structural Genomics Consortium

Ed Griffen ASAP Discovery Project Lead on Lead Optimization & Technical Director, MedChemica

Session Chair: Owen Roberts Conscience Board Member & CEO of the Centre for Probe Development and Commercialization (CPDC)

Oren Kraus Associate Director of Machine Learning at Recursion Pharma

Benjamin Haibe-Kains Head of Data Science at the Structural Genomics Consortium, Senior Scientist at the Princess Margaret Cancer Centre, & Associate Professor in the Medical Biophysics department of the University of Toronto

Session Chair: Yogesh Sabnis Director, Lead Molecular Design, UCB Biopharma

Karina Machado Associate Professor at the Federal University of Rio Grande (FURG) and coordinator of the Computational Biology Laboratory (ComBi-Lab)

Daniel Cole Reader & UKRI Future Leaders Fellow in Computational Chemistry, Newcastle University

Francesco Gentile Assistant Professor, Department of Chemistry and Biomolecular Sciences, University of Ottawa

Mykola Protopopov Head of Computational Chemistry at Chemspace